NASDAQ:ZIVO ZIVO Bioscience (ZIVO) Stock Price, News & Analysis → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free ZIVO Stock Alerts $8.00 +1.10 (+15.94%) (As of 04/18/2024 ET) Add Compare Share Share Today's Range$6.90▼$8.0050-Day Range$6.81▼$9.5052-Week Range$0.48▼$19.08Volume270 shsAverage Volume6,378 shsMarket Capitalization$22.40 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get ZIVO Bioscience alerts: Email Address Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! About ZIVO Bioscience Stock (NASDAQ:ZIVO)ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.Read More ZIVO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ZIVO Stock News HeadlinesMarch 18, 2024 | investorplace.comZIVO Stock Earnings: Zivo Bioscience Reported Results for Q4 2023March 4, 2024 | forbes.comHarmony Biosciences HoldingsApril 18, 2024 | Gold Safe Exchange (Ad)The “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.February 1, 2024 | morningstar.comRegencell Bioscience Holdings Ltd RGCJanuary 29, 2024 | finance.yahoo.comZIVO Bioscience Announces Uplisting to OTCQB MarketJanuary 18, 2024 | forbes.comIdeaya BiosciencesJanuary 14, 2024 | morningstar.comDare Bioscience Inc DARENovember 2, 2023 | msn.comZivo Bioscience (ZIVO) Price Target Increased by 500.00% to 36.72April 18, 2024 | Gold Safe Exchange (Ad)The “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.November 1, 2023 | morningstar.comZivo Bioscience Inc ZIVOOctober 30, 2023 | finance.yahoo.comZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler ChickensOctober 26, 2023 | markets.businessinsider.comZivo Bioscience Announces 1-for-6 Reverse Stock Split To Regain ComplianceOctober 26, 2023 | msn.comZivo Bioscience to effect reverse stock split to regain compliance with Nasdaq rulesOctober 3, 2023 | finance.yahoo.comZIVO Bioscience to Present at the Dawson James Small Cap Growth ConferenceSeptember 19, 2023 | finance.yahoo.comTrial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler ChickensAugust 16, 2023 | businesswire.comZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife ™ Algal Biomass Product Produced Over the Next 18 MonthsAugust 16, 2023 | marketwatch.comZivo Bioscience: ZWorldwide to Buy All Zivolife Supply for First 18 Months of AgreementAugust 16, 2023 | finance.yahoo.comZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 MonthsJuly 26, 2023 | finance.yahoo.comZIVO Commences Sales of its Proprietary Algal Biomass as Human FoodJune 29, 2023 | marketwatch.comZivo Bioscience Shares Jump Premarket After Dropping Plans for Securities OfferingMay 30, 2023 | benzinga.comZIVO's GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food IngredientMay 30, 2023 | finance.yahoo.comZIVO’s GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food IngredientMay 10, 2023 | investing.comSK Bioscience Co Ltd (302440)April 5, 2023 | msn.comZivo Bioscience gets $1M loan from CEOMarch 17, 2023 | markets.businessinsider.comMaxim Group Keeps Their Buy Rating on Zivo Bioscience (ZIVO)February 10, 2023 | marketwatch.comZivo Bio Shares Slide 23% on High Mortality Rate in Coccidiosis Treatment StudyFebruary 10, 2023 | marketwatch.comStocks to Watch: Blue Apron, Zivo Bioscience, Berkshire GreySee More Headlines Receive ZIVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ZIVO Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/15/2024Today4/18/2024Next Earnings (Estimated)5/10/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:ZIVO Previous SymbolOTCMKTS:HEPI CUSIPN/A CIK1101026 Webwww.zivobioscience.com Phone(248) 452-9866FaxN/AEmployees8Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($4.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,780,000.00 Net MarginsN/A Pretax Margin-28,126.58% Return on EquityN/A Return on Assets-691.99% Debt Debt-to-Equity RatioN/A Current Ratio0.15 Quick Ratio0.15 Sales & Book Value Annual Sales$30,000.00 Price / Sales746.67 Cash FlowN/A Price / Cash FlowN/A Book Value($0.81) per share Price / Book-9.88Miscellaneous Outstanding Shares2,800,000Free Float2,427,000Market Cap$22.40 million OptionableNot Optionable Beta0.20 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. John B. Payne (Age 76)President, CEO & Chairman of the Board Comp: $572.75kMr. Keith R. Marchiando (Age 62)CFO, Treasurer & Secretary Comp: $362.5kDr. Harlan L. Miller IIIVice President of Technology & Global SupplyKey CompetitorsSurrozenNASDAQ:SRZNAptose BiosciencesNASDAQ:APTOPharmaCyte BiotechNASDAQ:PMCBEvaxion Biotech A/SNASDAQ:EVAXNKGen BiotechNYSE:NKGNView All CompetitorsInsidersMark E StromeBought 40,000 shares on 6/2/2023Total: $199,600.00 ($4.99/share)View All Insider Transactions ZIVO Stock Analysis - Frequently Asked Questions How have ZIVO shares performed in 2024? ZIVO Bioscience's stock was trading at $1.20 at the beginning of the year. Since then, ZIVO shares have increased by 566.7% and is now trading at $8.00. View the best growth stocks for 2024 here. When is ZIVO Bioscience's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024. View our ZIVO earnings forecast. How were ZIVO Bioscience's earnings last quarter? ZIVO Bioscience, Inc. (NASDAQ:ZIVO) announced its earnings results on Friday, March, 15th. The biotechnology company reported ($0.96) earnings per share for the quarter. The biotechnology company had revenue of $0.01 million for the quarter. When did ZIVO Bioscience's stock split? Shares of ZIVO Bioscience reverse split on the morning of Friday, October 27th 2023. The 1-6 reverse split was announced on Friday, October 27th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. How do I buy shares of ZIVO Bioscience? Shares of ZIVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ZIVO) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZIVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.